3 3 CNS-ML Limited 12341517 false 2022-12-01 2024-04-30 2024-04-30 The principal activity of the company is General Medical Practice Activities Digita Accounts Production Advanced 6.30.9574.0 true 12341517 2022-12-01 2024-04-30 12341517 2024-04-30 12341517 core:CurrentFinancialInstruments 2024-04-30 12341517 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 12341517 core:FurnitureFittings 2024-04-30 12341517 core:OfficeEquipment 2024-04-30 12341517 core:PlantMachinery 2024-04-30 12341517 bus:SmallEntities 2022-12-01 2024-04-30 12341517 bus:AuditExemptWithAccountantsReport 2022-12-01 2024-04-30 12341517 bus:FilletedAccounts 2022-12-01 2024-04-30 12341517 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2024-04-30 12341517 bus:RegisteredOffice 2022-12-01 2024-04-30 12341517 bus:Director1 2022-12-01 2024-04-30 12341517 bus:Director2 2022-12-01 2024-04-30 12341517 bus:PrivateLimitedCompanyLtd 2022-12-01 2024-04-30 12341517 bus:Agent1 2022-12-01 2024-04-30 12341517 core:FurnitureFittings 2022-12-01 2024-04-30 12341517 core:OfficeEquipment 2022-12-01 2024-04-30 12341517 core:PlantMachinery 2022-12-01 2024-04-30 12341517 countries:AllCountries 2022-12-01 2024-04-30 12341517 2022-11-30 12341517 core:FurnitureFittings 2022-11-30 12341517 core:OfficeEquipment 2022-11-30 12341517 core:PlantMachinery 2022-11-30 12341517 2021-12-01 2022-11-30 12341517 2022-11-30 12341517 core:CurrentFinancialInstruments 2022-11-30 12341517 core:CurrentFinancialInstruments core:WithinOneYear 2022-11-30 12341517 core:FurnitureFittings 2022-11-30 12341517 core:OfficeEquipment 2022-11-30 12341517 core:PlantMachinery 2022-11-30 xbrli:pure iso4217:GBP

Registration number: 12341517

CNS-ML Limited

Unaudited Filleted Financial Statements

for the Period from 1 December 2022 to 30 April 2024

 

CNS-ML Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 9

 

CNS-ML Limited

Company Information

Directors

Dr Richard Mannion

Mrs Natalie Mannion

Registered office

5 High Green
Great Shelford
Cambridge
United Kingdom
CB22 5EG

Accountants

Tayabali & White 5 High Green
Great Shelford
Cambridge
CB22 5EG

 

CNS-ML Limited

(Registration number: 12341517)
Balance Sheet as at 30 April 2024

Note

2024
£

2022
£

Fixed assets

 

Tangible assets

4

64,381

5,557

Investment property

5

929,116

929,116

 

993,497

934,673

Current assets

 

Debtors

6

662,295

597,891

Cash at bank and in hand

 

612,772

30,123

 

1,275,067

628,014

Creditors: Amounts falling due within one year

7

(295,398)

(195,838)

Net current assets

 

979,669

432,176

Net assets

 

1,973,166

1,366,849

Capital and reserves

 

Called up share capital

8

24

24

Retained earnings

1,973,142

1,366,825

Shareholders' funds

 

1,973,166

1,366,849

For the financial period ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 30 January 2025 and signed on its behalf by:
 

 

CNS-ML Limited

(Registration number: 12341517)
Balance Sheet as at 30 April 2024

.........................................
Dr Richard Mannion
Director

 

CNS-ML Limited

Notes to the Unaudited Financial Statements for the Period from 1 December 2022 to 30 April 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The company's registered number is 12341517.

The address of its registered office is:
5 High Green
Great Shelford
Cambridge
United Kingdom
CB22 5EG

These financial statements were authorised for issue by the Board on 30 January 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

CNS-ML Limited

Notes to the Unaudited Financial Statements for the Period from 1 December 2022 to 30 April 2024

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Investment property

Investment property is carried at fair value, derived from the current market prices for comparable real estate determined annually by external valuers. The valuers use observable market prices, adjusted if necessary for any difference in the nature, location or condition of the specific asset. Changes in fair value are recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

 

CNS-ML Limited

Notes to the Unaudited Financial Statements for the Period from 1 December 2022 to 30 April 2024

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 3 (2022 - 3).

 

CNS-ML Limited

Notes to the Unaudited Financial Statements for the Period from 1 December 2022 to 30 April 2024

4

Tangible assets

Fixtures and fittings
£

Plant and machinery
£

Office equipment
£

Total
£

Cost or valuation

At 1 December 2022

-

7,962

3,688

11,650

Additions

57,750

-

3,892

61,642

At 30 April 2024

57,750

7,962

7,580

73,292

Depreciation

At 1 December 2022

-

3,988

2,105

6,093

Charge for the period

-

993

1,825

2,818

At 30 April 2024

-

4,981

3,930

8,911

Carrying amount

At 30 April 2024

57,750

2,981

3,650

64,381

At 30 November 2022

-

3,974

1,583

5,557

5

Investment properties

2024
£

At 1 December

929,116

At 30 April

929,116

There has been no valuation of investment property by an independent valuer.

6

Debtors

Current

2024
£

2022
£

Trade debtors

271,911

264,368

Other debtors

390,384

333,523

 

662,295

597,891

 

CNS-ML Limited

Notes to the Unaudited Financial Statements for the Period from 1 December 2022 to 30 April 2024

7

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2022
£

Due within one year

 

Loans and borrowings

9

-

23,660

Trade creditors

 

5,646

1,008

Taxation and social security

 

289,752

171,170

 

295,398

195,838

8

Share capital

9

Loans and borrowings

Current loans and borrowings

2024
£

2022
£

Bank overdrafts

-

23,660

10

Dividends

2024

2022

£

£

 

 

11

Related party transactions

 

CNS-ML Limited

Notes to the Unaudited Financial Statements for the Period from 1 December 2022 to 30 April 2024

Directors' remuneration

The directors' remuneration for the period was as follows:

2024
£

2022
£

Remuneration

44,767

29,716

Contributions paid to money purchase schemes

42,500

30,000

87,267

59,716